SEC Form 4 · accession 0001127602-17-018054
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard F Wallman
Director
Period of report
May 12, 2017
Accepted (ET)
May 15, 2017 · 3:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 12, 2017 | A | 2,436 | $0.00 | A | 23,426 | D | |
| Common Stock | May 12, 2017 | A | 822 | $0.00 | A | 24,248 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Consists of 2,436 unvested restricted stock units that vest upon the earlier of May 12, 2018, or the business day prior to the Company's next annual meeting of shareholders.
- F2This grant was made in lieu of director services fees for the term commencing May 9, 2017, and includes the fee he receives for being Chair of the Finance Committee, which was established on January 1, 2017. The restricted stock units vest upon the earlier of 5/12/2018, or the business day prior to the Company's next annual meeting of shareholders.